State Efforts to Reduce Consumers’ Cost-Sharing for Prescription Drugs
As drug prices have been rising, insurers have been shifting the costs to consumers by creating specialty drug tiers that require patients to pay a large percentage of the total cost or very high copays. This blog post looks at how a number of states have already moved ahead with legislative and regulatory action to help consumers. The authors outline states’ approaches to addressing this issue, including caps on drug spending and, within state marketplaces, standardized insurance benefit designs that limit the number of drug tiers or have fixed copayments.
